Manufacturing News and Research

RSS
LGR announces significant price reduction for new greenhouse gas analyzer

LGR announces significant price reduction for new greenhouse gas analyzer

Sleep Innovations launches REMedy Bed Upgrade Kit for students

Sleep Innovations launches REMedy Bed Upgrade Kit for students

Artificial nanoparticles have direct effect on heart rate and rhythm

Artificial nanoparticles have direct effect on heart rate and rhythm

Majority of infants consume more salt than recommended

Majority of infants consume more salt than recommended

Spectros reports 51% increase in year-to-date Oximeter sales revenue for 2011

Spectros reports 51% increase in year-to-date Oximeter sales revenue for 2011

Pharmalucence selects Bosch to provide isolated filling line for Billerica production facility

Pharmalucence selects Bosch to provide isolated filling line for Billerica production facility

Sorin Group second quarter revenues increase 0.6% to €191.9 million

Sorin Group second quarter revenues increase 0.6% to €191.9 million

Anthera reports increase in second quarter total operating expenses to $22.7 million

Anthera reports increase in second quarter total operating expenses to $22.7 million

Pew director issues statement on Prescription Drug User Fee Act hearing

Pew director issues statement on Prescription Drug User Fee Act hearing

BTI's IPOXYN data on traumatic shock and ischemia to be presented at XIIIth MGH symposium

BTI's IPOXYN data on traumatic shock and ischemia to be presented at XIIIth MGH symposium

Sigma-Tau, Soligenix expand partnership to develop and commercialize orBec in Europe

Sigma-Tau, Soligenix expand partnership to develop and commercialize orBec in Europe

RegeneRx to initiate enrollment in RGN-259 Phase 2 trial for dry eye syndrome

RegeneRx to initiate enrollment in RGN-259 Phase 2 trial for dry eye syndrome

Yaupon seeks FDA marketing approval of mechlorethamine gel for mycosis fungoides

Yaupon seeks FDA marketing approval of mechlorethamine gel for mycosis fungoides

Curis second quarter net loss increases to $4.9 million

Curis second quarter net loss increases to $4.9 million

TRTB announces supplier contract with Nada Marketing

TRTB announces supplier contract with Nada Marketing

Dr. Reddy's, FUJIFILM sign MoU to enter partnership in the generic drugs business

Dr. Reddy's, FUJIFILM sign MoU to enter partnership in the generic drugs business

Biosign closes brokered private placement for $1,900,000

Biosign closes brokered private placement for $1,900,000

FDA makes regulatory process for previously cleared 510(k) medical devices less challenging

FDA makes regulatory process for previously cleared 510(k) medical devices less challenging

Watson to acquire portfolio of divested generic pharmaceutical products

Watson to acquire portfolio of divested generic pharmaceutical products

Safeguard Scientifics reports consolidated net income of $121.8M for second quarter 2011

Safeguard Scientifics reports consolidated net income of $121.8M for second quarter 2011

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.